Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Dextenza

Drug Ophthalmology

NDC 70382-204-99

Open in the dashboard

General payments

$85,538

1,374 payments

Research payments

$602,288

37 payments

Through program year 2019, $85,538 in general payments and $602,288 in research payments were reported against Dextenza (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $85,538 1,374
2019 Research $602,288 37

Breakdown

Who paid General payments · program year 2019
  1. Ocular Therapeutix, Inc. $85,538 1,374 payments
Top recipients General payments · program year 2019
  1. Karl Stonecipher Ophthalmology · Greensboro, NC $4,143 5% · 4 payments
  2. Sydney Tyson Ophthalmology · Vineland, NJ $4,062 5% · 4 payments
  3. John Hovanesian Ophthalmology · Laguna Hills, CA $3,933 5% · 6 payments
  4. Cynthia Matossian Ophthalmology · Pennington, NJ $2,660 3% · 8 payments
  5. Steven Silverstein Ophthalmology · Kansas City, MO $2,466 3% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Ophthalmology $70,897 84% · 553 practitioners
  2. Optometrist $7,384 9% · 115 practitioners
  3. Retina Specialist Ophthalmology $1,948 2% · 20 practitioners
  4. Optometrist, Corneal and Contact Management Optometrist $1,482 2% · 7 practitioners
  5. Glaucoma Specialist Ophthalmology $669 <1% · 8 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $11,200 13% · 89 recipients
  2. Texas $9,500 11% · 91 recipients
  3. New York $9,378 11% · 85 recipients
  4. Florida $9,109 11% · 46 recipients
  5. North Carolina $8,492 10% · 31 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

1,374 general · 37 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record